--- title: "NHI Maintains Buy Rating as Capital Recycling Supports FAD Outlook and Valuation vs. Unchanged $90 Price Target" type: "News" locale: "en" url: "https://longbridge.com/en/news/285136603.md" description: "National Health Investors (NHI) received a Buy rating from analyst Juan C. Sanabria of BMO Capital, maintaining a $90 price target. Despite a reduction in 2026 funds available for distribution due to a $580 million exit, NHI's normalized FAD of $1.29 exceeded estimates, indicating strong cash flows. The company is actively repositioning its portfolio and successfully recycling capital, with $212 million in closed transactions this year. Sanabria believes that if NHI executes its investment pipeline, it can restore FAD momentum, making the current valuation attractive." datetime: "2026-05-05T00:15:24.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285136603.md) - [en](https://longbridge.com/en/news/285136603.md) - [zh-HK](https://longbridge.com/zh-HK/news/285136603.md) --- # NHI Maintains Buy Rating as Capital Recycling Supports FAD Outlook and Valuation vs. Unchanged $90 Price Target National Health Investors, the Real Estate sector company, was revisited by a Wall Street analyst yesterday. Analyst Juan C. Sanabria from BMO Capital maintained a Buy rating on the stock and has a $90.00 price target. ### Claim 55% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Juan C. Sanabria has given his Buy rating due to a combination of factors that balance near-term headwinds with improving capital deployment. While NHI reduced its 2026 funds available for distribution outlook following the previously disclosed $580 million National HealthCare exit, the quarter’s normalized FAD of $1.29 modestly surpassed both Street and BMO estimates, underscoring resilient underlying cash flows. The ex-Holiday senior housing operating portfolio remains a soft spot and may require further pruning, but management is actively repositioning assets and refining the portfolio mix. At the same time, NHI is successfully recycling capital, with letters of intent steadily converting into closed transactions, totaling about $212 million year to date and supporting an expanding $560 million investment pipeline. The recent reset of Bickford’s lease at a higher level, including the expectation of percentage rent, should bolster future rent growth and help offset the earnings drag from the NHC exit. In Sanabria’s view, if NHI executes on this investment pipeline and delivers on its SHOP growth expectations, the company can restore FAD momentum, making the current valuation attractive relative to its unchanged $90 price target. Accordingly, the risk-reward profile remains favorable, justifying a Buy recommendation despite the guidance cut. According to TipRanks, C. Sanabria is a 3-star analyst with an average return of 2.8% and a 51.99% success rate. C. Sanabria covers the Real Estate sector, focusing on stocks such as Cubesmart, Welltower, and National Health Investors. In another report released on April 22, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $94.00 price target. ### Related Stocks - [NHI.US](https://longbridge.com/en/quote/NHI.US.md) - [BMO.US](https://longbridge.com/en/quote/BMO.US.md) - [NHC.US](https://longbridge.com/en/quote/NHC.US.md) - [CUBE.US](https://longbridge.com/en/quote/CUBE.US.md) - [WELL.US](https://longbridge.com/en/quote/WELL.US.md) ## Related News & Research - [VIRGINIA RETIREMENT SYSTEMS ET Al Has $3.80 Million Stock Holdings in National Health Investors, Inc. $NHI](https://longbridge.com/en/news/286552098.md) - [NHI Announces the Second Quarter 2026 Dividend | NHI Stock News](https://longbridge.com/en/news/285115848.md) - [Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4](https://longbridge.com/en/news/286958909.md) - [Why This Analyst Thinks Texas Instruments Stock Is on the Path to $1 Trillion](https://longbridge.com/en/news/286957345.md) - [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)